• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.10% Nasdaq Down 1.82%

    Alkermes plc (ALKS)

    -NasdaqGS
    29.45 Down 2.72(8.46%) Feb 8, 4:00PM EST
    |After Hours : 29.37 Down 0.08 (0.27%) Feb 8, 4:59PM EST
    Prev Close:32.17
    Open:31.34
    Bid:25.25 x 300
    Ask:35.94 x 100
    1y Target Est:51.60
    Beta:2.25252
    Next Earnings Date:N/A
    Day's Range:28.73 - 31.41
    52wk Range:28.73 - 80.71
    Volume:1,593,894
    Avg Vol (3m):1,393,310
    Market Cap:4.42B
    P/E (ttm):N/A
    EPS (ttm):-0.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALKSDown 8.46%4.42B
    LLYDown 0.17%78.57B
    GSKDown 3.16%95.52B
    ABTUp 0.13%55.88B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.54
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.39
    Quarterly EPS Est (Dec-15) :-0.18
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):3.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback